Jim Cramer Doesn’t Like This Health Care Stock, Sees No Reason To Buy Rambus
10/8/2026
Impact: -75
Technology
Jim Cramer expressed skepticism about Rambus Inc. (NASDAQ: RMBS), stating he sees no reason to buy the stock due to a lack of catalysts, as it has not intrigued him. Rambus is scheduled to hold a conference call on October 26 to discuss its third-quarter results. Recently, Rambus shares fell by 2.3% to close at $111.48.
AI summary, not financial advice
Share: